期刊文献+

伴显著血小板增多的难治性环铁幼粒细胞性贫血一例 被引量:2

原文传递
导出
摘要 1 病例介绍 患者 女,61岁。因“乏力3个月,加重1周”于2012年6月5日入院。入院前3个月患者因全身酸痛、乏力就诊于我院门诊,血常规示:血小板计数(PLT)升高达965×10^9/L,血红蛋白(Hb)106g/L,白细胞计数(WBC)9×10^9/L,中性粒细胞比例64%,淋巴细胞比例36%;外周血JAK2 V617F基因突变呈阳性;诊断为“原发性血小板增多症(ET)”。
出处 《华西医学》 CAS 2014年第5期995-996,共2页 West China Medical Journal
  • 相关文献

参考文献5

  • 1Gupta R,Abdalla SH,Bain BJ.Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome[J].Leuk Lymphoma,1999,34(5/6): 615-619.
  • 2G?man M,Vl?d?reanu AM,Radesi S,et al.The implications of revised WHO classification (2008) of chronic myeloid neoplasms[J].Rom J Intern Med,2011,49(1): 25-30.
  • 3Huls G,Mulder AB,Rosati S,et al.Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis[J].Blood,2010,116(2): 180-182.
  • 4Kim J,Kim YR,Lee KA.Refractory anemia with ring sideroblasts associated with marked thrombocytosis harboring cytogenetic abnormality dup(2)(p15p22) treated with decitabine[J].Leuk Lymphoma,2012,53(11): 2287-2289.
  • 5Broseus J,Florensa L,Zipperer E,et al.Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis[J].Haematologica,2012,97(7): 1036-1041.

同被引文献16

  • 1Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues [ M ]. Lyon : IARC Press ,2008:75 - 86.
  • 2Ghman M, Vltdeanu AM, Radesi S. The implications of revised WHO classification ( 2008 ) of chronic myeloid neoplasms [ J ]. Rom J Intern Med,2011,49( 1 ) :25 -30.
  • 3Ceesay MM,Lea NC, Ingram W. The JAK2 V617F mutation is rare in RARS but common in RARS -T[ J]. Leukemia,2006,20( 11 ) : 2060 - 2061.
  • 4Mohamed M. Refractory anemia with ring sideroblasts associated with thrombocytosis( RARS - T) [ J]. Blood,2014,123 (3) :314.
  • 5Szpurka H,Jankowska AM, Makishima H, et al. Spectrum of muta- tions in RARS - T patients includes TET2 and ASXL1 mutations [J]. Leuk Res,2010,34(8) :969 -973.
  • 6Adds L, Fenaux P. Immunomodulating drugs in myelodysplastic syndromes [J]. Hematol Am Soc Hematol Educ Program,2011,2 : 556 - 560.
  • 7Brosus J, Alpermann T, Wulfert M, et al. Age, JAK2 (V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombo- cytosis [ J]. Leukemia,2013,27 (9) : 1826 - 1831.
  • 8SWERDLOW S H, CAMPO E, HARRIS N L, et al. WHO classification of tumors of haematopoietic and lymphoid tissues [ M ]. Lyon : IARC Press,2008:75 - 86.
  • 9GaMAN M, VLaDaREANU A M, RADESI S. The im- plications of revised WHO classification ( 2008 ) of chronic myeloid neoplasms [ J ]. Rom J Intern Med, 2011,49(1) :25 -30.
  • 10MARIO C, ROSANGELA I. Ring sideroblasts and sider- oblastic anemias [ J ]. Haematologica, 2011,96 ( 6 ) : 789 - 792.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部